MAPK14 (p38α) inhibition effects against metastatic gastric cancer cells: A potential biomarker and pharmacological target

被引:27
作者
Mesquita, Felipe Pantoja [1 ]
Moreira-Nunes, Caroline Aquino [1 ]
da Silva, Emerson Lucena [1 ]
Lima, Luina Benevides [1 ]
Daniel, Julio Paulino [1 ]
Zuerker, William J. [2 ]
Brayner, Mirna [1 ]
Amaral de Moraes, Maria Elisabete [1 ]
Montenegro, Raquel Carvalho [1 ]
机构
[1] Univ Fed Ceara, Drug Res & Dev Ctr NPDM, Lab Pharmacogenet, St Cel Nunes Melo 1000, Fortaleza, Ceara, Brazil
[2] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA
关键词
Metastatic gastric cancer; Kinase inhibition; MAPK14; Drug target; Biomarker; P38; MAPK; BREAST-CANCER; UP-REGULATION; KAPPA-B; MIGRATION; PROLIFERATION; INVASION; EXPRESSION; PATHWAYS; SPREAD;
D O I
10.1016/j.tiv.2020.104839
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Gastric cancer has been considering one of the worst cancer types since it is diagnosed in advanced stages, currently in the metastatic stage. Therefore, the challenge is to find out a biomarker and a pharmacology target that would help face this worldwide health issue. In this sense, the mitogen-activated protein kinase (MAPK) signaling pathway has become an important aim of the studies in several cancers. Therefore, we evaluated the role of MAPK14 (p38 alpha) inhibitor SB-245392 in the cellular process, such as proliferation, cell death, and cell migration, and whether MAPK14 gene could be a potential biomarker in gastric cancer models. The results clearly suggest that p38 alpha inhibition significantly impairs the cell proliferation, induces modest apoptosis and strongly inhibits cell migration of gastric cancer cell (AGP-01). Gene expression analysis showed that c-MYC level was decreased and TP53 was increased after SB-245392 treatment. Furthermore, MAPK14 was found in high levels in gastric cancer samples compared to normal samples in the TCGA database, especially in advanced stages (stage 3 and 4), which is significantly associated with low rate survival of the patients. In conclusion, the MAPK14 could be a potential biomarker for advanced gastric cancer as well as a pharmacological target, which could improve the survival rate of patients.
引用
收藏
页数:8
相关论文
共 59 条
[1]   BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC [J].
Ba, Mingchen ;
Long, Hui ;
Yan, Zhaofei ;
Wang, Shuai ;
Wu, Yinbing ;
Tu, Yinuo ;
Gong, Yuanfeng ;
Cui, Shuzhong .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) :973-982
[2]   The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments [J].
Bustin, Stephen A. ;
Benes, Vladimir ;
Garson, Jeremy A. ;
Hellemans, Jan ;
Huggett, Jim ;
Kubista, Mikael ;
Mueller, Reinhold ;
Nolan, Tania ;
Pfaffl, Michael W. ;
Shipley, Gregory L. ;
Vandesompele, Jo ;
Wittwer, Carl T. .
CLINICAL CHEMISTRY, 2009, 55 (04) :611-622
[3]   MYC and gastric adenocarcinoma carcinogenesis [J].
Calcagno, Danielle Queiroz ;
Leal, Mariana Ferreira ;
Assumpcao, Paulo Pimentel ;
Cardoso Smith, Marilia de Arruda ;
Burbano, Rommel Rodriguez .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (39) :5962-5968
[4]   MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer [J].
Calcagno, Danielle Queiroz ;
Freitas, Vanessa Morais ;
Leal, Mariana Ferreira ;
Teixeira de Souza, Carolina Rosal ;
Demachki, Samia ;
Montenegro, Raquel ;
Assumpcao, Paulo Pimentel ;
Khayat, Andre Salim ;
Cardoso Smith, Marilia de Arruda ;
Ribeiro dos Santos, Andrea Kely Campos ;
Burbano, Rommel Rodriguez .
BMC GASTROENTEROLOGY, 2013, 13
[5]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[6]   Vimentin fibers orient traction stress [J].
Costigliola, Nancy ;
Ding, Liya ;
Burckhardt, Christoph J. ;
Han, Sangyoon J. ;
Gutierrez, Edgar ;
Mota, Andressa ;
Groisman, Alex ;
Mitchison, Timothy J. ;
Danuser, Gaudenz .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (20) :5195-5200
[7]   Mechanisms and functions of p38 MAPK signalling [J].
Cuadrado, Ana ;
Nebreda, Angel R. .
BIOCHEMICAL JOURNAL, 2010, 429 :403-417
[8]  
Darzynkiewicz Zbigniew, 2017, Curr Protoc Immunol, V119, DOI 10.1002/cpim.36
[9]   Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line [J].
Duzgun, Sukru Aydin ;
Yerlikaya, Azmi ;
Zeren, Sezgin ;
Bayhan, Zulfu ;
Okur, Emrah ;
Boyaci, Ihsan .
CYTOTECHNOLOGY, 2017, 69 (04) :711-724
[10]   Comprehensive characterization of the Published Kinase Inhibitor Set [J].
Elkins, Jonathan M. ;
Fedele, Vita ;
Szklarz, Marta ;
Azeez, Kamal R. Abdul ;
Salah, Eidarus ;
Mikolajczyk, Jowita ;
Romanov, Sergei ;
Sepetov, Nikolai ;
Huang, Xi-Ping ;
Roth, Bryan L. ;
Zen, Ayman Al Haj ;
Fourches, Denis ;
Muratov, Eugene ;
Tropsha, Alex ;
Morris, Joel ;
Teicher, Beverly A. ;
Kunkel, Mark ;
Polley, Eric ;
Lackey, Karen E. ;
Atkinson, Francis L. ;
Overington, John P. ;
Bamborough, Paul ;
Mueller, Susanne ;
Price, Daniel J. ;
Willson, Timothy M. ;
Drewry, David H. ;
Knapp, Stefan ;
Zuercher, William J. .
NATURE BIOTECHNOLOGY, 2016, 34 (01) :95-103